Vaccine

The structural architecture of the reovirus attachment protein is required for efficient reovirus infection of host cells. Read More

Understanding how antibodies with long “loops” form may be important for HIV vaccine development. Read More

New information may help speed development of a vaccine or treatment for dengue fever. Read More

A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults. Read More

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly. Read More

Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by The Journal of Infectious Diseases. Read More

This Week on VUCast: A shark attack victim inspires a bionic breakthrough; why political prices are going up; and making a cappella cool. [vucastblurb]    … Read More

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines. Read More

A report released by the Institute of Medicine confirms the safety of eight vaccines studied by a committee of experts. Evidence showed no links between immunization and serious conditions that have raised concerns, including Type 1 diabetes and autism. Read More

Vanderbilt researchers are seeking healthy adults ages 18-49 for a study testing a new vaccine against H5N1 influenza, a strain which has the potential to be the next pandemic flu virus. Read More